Retatrutide – 30MG

Retatrutide works through three hormone pathways that help regulate hunger, blood sugar, and energy use in the body.

• Reduces appetite and food cravings
• Helps you feel fuller for longer after meals
• Slows stomach emptying to support portion control
• Improves blood sugar regulation
• Supports increased calorie burning through metabolic signalling
• Encourages the body to use stored fat for energy

Because it works across multiple metabolic systems at once, retatrutide is being widely studied for weight-management support compared with earlier single-pathway peptides.

Retatrutide is still an investigational peptide and has not yet received full approval for general clinical use.

In controlled clinical studies, participants experienced average body-weight reductions of approximately
24.2% over 48 weeks.

Phase 3 studies are currently ongoing to confirm long-term safety and effectiveness.

Retatrutide is typically introduced gradually to allow the body to adjust comfortably.

• Weeks 1–2: 1mg once weekly
• Weeks 3–4: 2mg once weekly
• Weeks 5–8: 4mg once weekly
• Weeks 9–12: 8mg once weekly
• Week 13 onward: 12mg once weekly

Dosage progression may vary depending on individual response and guidance from a qualified healthcare professional.

• Strength: 30mg per vial
• Format: Lyophilised peptide powder
• Packaging: Sealed sterile vial
• Storage: Refrigeration recommended after mixing

Retatrutide is supplied as a freeze-dried powder and must be mixed before use.

• Reconstitute using bacteriostatic water
• Inject liquid slowly into the vial
• Store refrigerated after mixing
• Avoid shaking the vial

Retatrutide remains an investigational compound.

• Not yet approved for general medical use
• No medical advice or treatment guidance is provided
• Use should be discussed with a qualified healthcare professional